Global Health Limited

Symbol: GLH.AX

ASX

0.1

AUD

Market price today

  • -0.8970

    P/E Ratio

  • 0.0054

    PEG Ratio

  • 5.80M

    MRK Cap

  • 0.00%

    DIV Yield

Global Health Limited (GLH-AX) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

-0.11%

Operating Profit Margin

-0.25%

Net Profit Margin

-0.75%

Return on Assets

-3.32%

Return on Equity

2.96%

Return on Capital Employed

0.88%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO:Mr. Alumootil Mathew Ravi Cherian B.Bus(IS/IT), M.A.I.C.D., MACS, MAICD
Full-time employees:49
City:Melbourne
Address:696 Bourke Street
IPO:2000-04-03
CIK:

Global Health Limited provides digital health solutions for the healthcare sector in Australia. It provides mental health software for psychologists and psychiatrists; and integrated software solutions for various areas of community health and human services, including drug and alcohol, disability, post-acute care, community care, mental health services, and community rehabilitation, as well as offers software solutions for home care and aged care, consumer engagement tools, general practice, and pharmacy. The company's products include MasterCare EMR, an Electronic Medical Record; MasterCare + that helps organizations in digitizing their services and processes; MasterCare PAS, a patient administration system; PrimaryClinic, a medical and practice management software for general practitioners and specialists that share the same patient demographic. It also provides ReferralNet to send and receive various document types; LifeCard, a personal health record; and HotHealth, a digital engagement tool. In addition, the company offers MasterCare Data Warehouse that removes the need for spreadsheets, exports, and time-consuming analysis; e-switch, a middleware software to exchange data externally, internally, and between different software systems; Patient Portal, an online portal to capture patient data digitally via an online form prior to admission; and Altitude, a cloud hosting service. Global Health Limited was founded in 1985 and is headquartered in Melbourne, Australia.

General Outlook

When we look at how much money they make before expenses, they keep -0.114% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.252%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.746%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -3.323% return, is a testament to Global Health Limited's adeptness in optimizing resource deployment. Global Health Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 2.962%. Furthermore, the proficiency of Global Health Limited in capital utilization is underscored by a remarkable 0.879% return on capital employed.

Stock Prices

Global Health Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.125, while its low point bottomed out at $0.12. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Global Health Limited's stock market.

Liquidity Ratios

Analyzing GLH.AX liquidity ratios reveals its financial health of the firm. The current ratio of 43.74% gauges short-term asset coverage for liabilities. The quick ratio (39.19%) assesses immediate liquidity, while the cash ratio (31.57%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio43.74%
Quick Ratio39.19%
Cash Ratio31.57%

Profitability Ratios

GLH.AX profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -70.95% underscores its earnings before tax deductions. The effective tax rate stands at -5.14%, revealing its tax efficiency. The net income per EBT, 105.14%, and the EBT per EBIT, 281.25%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -25.23%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-70.95%
Effective Tax Rate-5.14%
Net Income per EBT105.14%
EBT per EBIT281.25%
EBIT per Revenue-25.23%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.44, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding39
Operating Cycle14.23
Days of Payables Outstanding35
Cash Conversion Cycle-21
Receivables Turnover25.65
Payables Turnover10.40
Inventory Turnover9660378.00
Fixed Asset Turnover1221.89
Asset Turnover4.45

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.04, and free cash flow per share, -0.04, depict cash generation on a per-share basis. The cash per share value, 0.02, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.26, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.04
Free Cash Flow per Share-0.04
Cash per Share0.02
Operating Cash Flow Sales Ratio-0.26
Free Cash Flow to Operating Cash Flow Ratio1.00
Cash Flow Coverage Ratio-5.16
Short Term Coverage Ratio-12.00
Capital Expenditure Coverage Ratio-1784.71
Dividend Paid and Capex Coverage Ratio-1784.71

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 22.71%, highlights its total liabilities relative to assets. With a debt-equity ratio of -0.16, we discern the balance between debt and equity financing. The long-term debt to capitalization, -10.09%, and total debt to capitalization, -19.16%, ratios shed light on its capital structure. An interest coverage of -30.87 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio22.71%
Debt Equity Ratio-0.16
Long Term Debt to Capitalization-10.09%
Total Debt to Capitalization-19.16%
Interest Coverage-30.87
Cash Flow to Debt Ratio-5.16
Company Equity Multiplier-0.71

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.14, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.14, reflects the portion of profit attributed to each share. The book value per share, -0.03, represents the net asset value distributed per share, while the tangible book value per share, -0.03, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share0.14
Net Income Per Share-0.14
Book Value Per Share-0.03
Tangible Book Value Per Share-0.03
Shareholders Equity Per Share-0.03
Capex Per Share-0.02

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -7.01%, indicates top-line expansion, while the gross profit growth, -7.01%, reveals profitability trends. EBIT growth, -561.20%, and operating income growth, -561.20%, offer insights into operational profitability progression. The net income growth, -312.72%, showcases bottom-line expansion, and the EPS growth, -212.82%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-7.01%
Gross Profit Growth-7.01%
EBIT Growth-561.20%
Operating Income Growth-561.20%
Net Income Growth-312.72%
EPS Growth-212.82%
EPS Diluted Growth-212.82%
Weighted Average Shares Growth32.20%
Weighted Average Shares Diluted Growth32.20%
Free Cash Flow Growth-490.18%
10-Year Revenue Growth per Share-27.02%
5-Year Revenue Growth per Share-23.05%
3-Year Revenue Growth per Share-24.26%
10-Year Operating CF Growth per Share-167.70%
10-Year Net Income Growth per Share-194.76%
5-Year Net Income Growth per Share-384.62%
3-Year Net Income Growth per Share-2.54%
10-Year Shareholders Equity Growth per Share130.29%
5-Year Shareholders Equity Growth per Share-16.72%
3-Year Shareholders Equity Growth per Share623.87%
3-Year Dividend per Share Growth per Share-100.00%
Receivables Growth-1.15%
Inventory Growth117.86%
Asset Growth22.69%
Book Value per Share Growth13.95%
Debt Growth-53.36%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 5,565,670.09, captures the company's total value, considering both debt and equity. Income quality, 0.43, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.12, gauges operational efficiency, while the research and development to revenue, 34.37%, highlights investment in innovation.

cards.indicatorcards.value
Enterprise Value5,565,670.09
Income Quality0.43
Sales General and Administrative to Revenue0.12
Research and Development to Revenue34.37%
Capex to Operating Cash Flow25.81%
Capex to Revenue-11.43%
Capex to Depreciation-183.21%
Stock-Based Compensation to Revenue0.24%
Graham Number0.30
Return on Tangible Assets-258.19%
Graham Net Net-0.03
Working Capital-1,581,996
Tangible Asset Value-1,619,656
Net Current Asset Value-1,628,593
Average Receivables623,937
Average Payables602,408
Average Inventory0.5
Days Sales Outstanding33
Days Payables Outstanding23
ROIC247.71%
ROE4.97%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -2.11, and the price to book ratio, -2.11, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.67, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -2.54, and price to operating cash flows, -2.55, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio-2.11
Price to Book Ratio-2.11
Price to Sales Ratio0.67
Price Cash Flow Ratio-2.55
Price Earnings to Growth Ratio0.01
Enterprise Value Multiple-3.70
Price Fair Value-2.11
Price to Operating Cash Flow Ratio-2.55
Price to Free Cash Flows Ratio-2.54
Price to Tangible Book Ratio-4.79
Enterprise Value to Sales0.71
Enterprise Value Over EBITDA-1.72
EV to Operating Cash Flow-1.61
Earnings Yield-103.73%
Free Cash Flow Yield-56.09%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Global Health Limited (GLH.AX) on the ASX in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.897 in 2024.

What is the ticker symbol of Global Health Limited stock?

The ticker symbol of Global Health Limited stock is GLH.AX.

What is company IPO date?

IPO date of Global Health Limited is 2000-04-03.

What is company current share price?

Current share price is 0.100 AUD.

What is stock market cap today?

The market cap of stock today is 5804950.000.

What is PEG ratio in 2024?

The current 0.005 is 0.005 in 2024.

What is the number of employees in 2024?

In 2024 the company has 49.